During the past decade, Rex Cancer Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 30 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rex Cancer Center" #1 sponsor was "UNC Lineberger Comprehensive Cancer Center" with 12 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "Dana-Farber Cancer Institute" with 5 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rex Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Rex Cancer Center" are "Breast Cancer" (11 trials), "Prostate Cancer" (7 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (4 trials) and "Estrogen Receptor Negative" (2 trials). Many other conditions were trialed in "Rex Cancer Center" in a lesser frequency.

Most popular intervention types in "Rex Cancer Center" are "Drug" (46 trials), "Other" (15 trials), "Radiation" (13 trials), "Biological" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (4 trials), "placebo" (4 trials), "radiation therapy" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rex Cancer Center" are 38 trials for "All" genders, 8 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Rex Cancer Center". undefined are not yet recruiting, 7 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Rex Cancer Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Rex Cancer Center, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".